Danish Crown slaughterhouse closed on suspicion of swine fever

http://cphpost.dk/news/business/danish-crown-slaughterhouse-closed-on-suspicion-of-swine-fever.html

Russian Scientist: ASF could become a human health risk

"The African swine fever (ASF) virus, may in the future become dangerous for humans, according to the head of the Russian Epidemiology Service, Chief State Sanitary Doctor Gennady Onishchenko, at the press-conference in St. Petersburg. According to him almost all viruses from time to time go through mutation processes which can give them some additional functions."

 http://www.pigprogress.net/Health-Diseases/Outbreaks/2013/7/ASF-could-become-a-human-health-risk-1308047W/

 

 

Background on African Swine Fever Virus as a human pathogen:

"African Swine fever is an endemic disease in sub-Saharan Africa and many other parts of the developing world. It is caused by the African Swine virus that primarily replicates in macrophages and monocytes leading to the impairment of the structure and function of the immune system of the infected organisms. Until now the African Swine epidemic continues to spread despite all efforts to contain it. Thus, there is an objective need for effective, safe and affordable preventive and therapeutic approaches, in particular for effective vaccines, to control and eventually eradicate this disease. Since the characteristic feature of the African Swine virus is to impair the immune system and to cause immune deficiencies in its hosts the development of vaccines and other therapeutic approaches against the African Swine virus has implications for other immune deficiencies or diseases. Several other viruses are also known to cause immunodeficiency-like syndromes in humans, including cytomegalovirus, Epstein Barr Virus and others. Moreover, a series of cases of so-called "idiopathic" immunodeficiencies have been documented that display CD4+T-lymphocytopenia with opportunistic infections, but show no evidence of HIV infection. Since antibodies for the African Swine virus have been detected in humans, the possibility of human infection with the African Swine virus exists and may thus far have escaped any systematic screening. Thus, any preventive and therapeutic approach to African Swine fever can have far-reaching implications to control immune deficiency conditions in humans."http://www.faqs.org/patents/app/20080207875

Detection of Novel Sequences Related to African Swine Fever Virus in Human Serum and Sewage.

Loh J, Zhao G, Presti RM, Holtz LR, Finkbeiner SR, Droit L, Villasana Z, Todd C, Pipas JM, Calgua B, Girones R, Wang D, Virgin HW.

Departments of Pathology & Immunology and Molecular Microbiology, Department of Medicine and Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology, Faculty of Biology, University of Barcelona, Barcelona, Spain.

"The family Asfarviridae contains only a single virus species, African swine fever virus (ASFV). ASFV is a viral agent with significant economic impact due to its devastating effects on populations of domesticated pigs during outbreaks, but has not been reported to infect humans. We report here the discovery of novel viral sequences in human serum and sewage which are clearly related to the Asfarvirus family, but highly divergent from ASFV. Detection of these sequences suggests that greater genetic diversity may exist among Asfarviruses than previously thought, and raises the possibility that human infection by Asfarviruses may occur."

http://www.ncbi.nlm.nih.gov/pubmed/19812170?dopt=Abstract

African Swine Fever Virus (Asfarviridae) sequences found in people with febrile illnesses

Abstract

Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep Sequencing

Dengue virus is an emerging infectious agent that infects an estimated 50–100 million people annually worldwide, yet current diagnostic practices cannot detect an etiologic pathogen in ∼40% of dengue-like illnesses. Metagenomic approaches to pathogen detection, such as viral microarrays and deep sequencing, are promising tools to address emerging and non-diagnosable disease challenges. In this study, we used the Virochip microarray and deep sequencing to characterize the spectrum of viruses present in human sera from 123 Nicaraguan patients presenting with dengue-like symptoms but testing negative for dengue virus. We utilized a barcoding strategy to simultaneously deep sequence multiple serum specimens, generating on average over 1 million reads per sample. We then implemented a stepwise bioinformatic filtering pipeline to remove the majority of human and low-quality sequences to improve the speed and accuracy of subsequent unbiased database searches. By deep sequencing, we were able to detect virus sequence in 37% (45/123) of previously negative cases. These included 13 cases with Human Herpesvirus 6 sequences. Other samples contained sequences with similarity to sequences from viruses in the Herpesviridae, Flaviviridae, Circoviridae, Anelloviridae, Asfarviridae, and Parvoviridae families. In some cases, the putative viral sequences were virtually identical to known viruses, and in others they diverged, suggesting that they may derive from novel viruses. These results demonstrate the utility of unbiased metagenomic approaches in the detection of known and divergent viruses in the study of tropical febrile illness.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274504/

Detection of African swine fever virus-like sequences in ponds in the Mississippi Delta through metagenomic sequencing

" . .. further study is needed to characterize their potential risks to both public health and agricultural development."

http://link.springer.com/article/10.1007%2Fs11262-013-0878-2

ASF virus, adapted to grow in VERO cells, produces a strong cytopathic effect in human macrophages leading to cell destruction.

http://vir.sgmjournals.org/content/34/3/455.short

Memo to Gallo and Ablashi:

Development of African swine fever diagnostic assays for oral fluids 

 http://research.pork.org/Results/ResearchDetail.aspx?id=1835

New ASF outbreaks raise concerns over future of Ukraine pig industry

By Vladislav Vorotnikov, 29-Oct-2015

Meat industry executives in Ukraine have warned that African swine fever is posing a serious threat to the country’s pig industry, following the discovery of several new outbreaks of the disease, including in the Sumy, Poltava, Odessa and Mykolaiv Oblasts. 

http://www.globalmeatnews.com/Industry-Markets/New-ASF-outbreaks-raise-concerns-over-future-of-Ukraine-pig-industry

The African Swine Fever Virus Rights of Man

1. The right not to be lied to about whether African Swine Fever Virus is infecting human beings.

2. The right not to be lied to about how many different strains of African Swine Fever are capable of infecting humans.

3. The right to know if African Swine Fever is being disguised in pigs by giving it euphemisms of other diseases like PRRS and PEDV.

4. The right not to be lied to about the role of ASFV in AIDS.

5. The right not to be lied to about the role of ASFV in Chronic Fatigue Syndrome.

6. The right not to be lied to about the role of ASFV in Autism.

7.The right not to be lied to about the role of ASFV in Multiple Sclerosis.

8. The right not to be lied to about the role of ASFV in Brain Cancer.

9. The right not to be lied to about the role of ASFV in Heart Disease.

10. The right not to be lied to about the role of ASFV in Encephalitis.

11. The right not to be lied to about the role of ASFV in Cognitive Dysfunction.

12. The right not to be lied to about the role of ASFV in Drug Hypersensitivity Syndrome.

13. The right not to be lied to about the role of ASFV in Bone Marrow Suppression.

14. The right not to be lied to about the role of ASFV in Lymphadenopathy.

 15. The right not to be lied to about the role of ASFV in Colitis.

16. The right not to be lied to about the role of ASFV in Endocrine Disorders.

17. The right not to be lied to about the role of ASFV in Liver Disease.

 18. The right not to be lied to about the role of ASFV in Hodgkin's Lymphoma.

 19. The right not to be lied to about the role of ASFV in Glioma.

20. The right not to be lied to about the role of ASFV in Cervical Cancer.

21. The right not to be lied to about the role of ASFV in Hypogammaglobulinemia.

 22. The right not to be lied to about the role of ASFV in Optic Neuritis.

23. The right not to be lied to about the role of ASFV in Microangiopathy.

24. The right not to be lied to about the role of ASFV in Mononucleosis.

25. The right not to be lied to about the role of ASFV in Uveitis.

26. The right not to be lied to about the role of ASFV in Stevens-Johnson Syndrome.

27. The right not to be lied to about the role of ASFV in Rhomboencephalitis.

28. The right not to be lied to about the role of ASFV in Limbic Encephalitis.

29. The right not to be lied to about the role of ASFV in Encephalomyelitis

30. The right not to be lied to about the role of ASFV in Pneumonitis.

31. The right not to be lied to about the role of ASFV in GVHD.

32. The right not to be lied to about the role of ASFV in Ideopathic Pneumonia.

33. The right not to be lied to about the role of ASFV in Pediatric Adrenocortical Tumors

34. The right not to be lied to about the role of ASFV in the reactivation of endogenous retroviruses.

35. The right not to be lied to about the impact of ASFV on T-Cells.

36. The right not to be lied to about the impact of ASFV on B-Cells

37. The right not to be lied to about the impact of ASFV on Epithelial Cells.

38. The right not to be lied to about the the impact of ASFV on Natural Killer Cells.

39. The right not to be lied to about the the impact of HHV-6 on Dendritic Cells.

40. The right not to be lied to about the the impact of ASFV infection of the brain.

 41. The right not to be lied to about the the impact of ASFV infection of the liver.

42. The right not to lied to about the ability of ASFV to affect cytokine production.

43. The right not to be lied to about the ability of ASFV to affect Aortic and Heart Microvascular Endothelial cells.

44. The right not be lied to about the relationship of ASFV to HHV-6, HHV-7 and HHV-8. 





Background: 

John Beldekas and Robert Gallo  on HHV-6 and 
African Swine Fever Virus 

In August, 1986, John Beldekas was invited to go to the NCI and present his findings on the link between ASFV [African Swine Fever virus] and AIDS, which he did. Beldekas gave samples of all his lab work to Gallo. Later, the government asked Beldekas to turn over all his reagents and lab work to the government, which he did. Beldekas had found ASFV presence in nine of 21 AIDS patients using two standard procedures. At the meeting, Gallo was reported saying: “we know it is not ASFV.” How could Gallo know this as he hadn’t done any of his own tests to look for ASFV?
Two months later, Gallo published an article in Science (Oct 31, 1986) that he discovered a new possible co-factor in AIDS, a virus he called Human B Cell Lymphotropic Virus which he named HBLV. Like ASFV, HBLV infected B cells and also lived in macrophages. Did Gallo steal Beldekas’s ASF virus he found in AIDS patients and rename it HBLV? Later on, when Gallo found that HBLV could also infect other immune cells, he changed the name of HBLV to HHV-6. Eventually, Gallo identified his HBLV as the variant A strain of HHV-6 and called it a human herpesvirus.
--Mark Konlee

http://www.keephopealive.org/report10.html

Russian Scientist: ASF could become a human health risk

"The African swine fever (ASF) virus, may in the future become dangerous for humans, according to the head of the Russian Epidemiology Service, Chief State Sanitary Doctor Gennady Onishchenko, at the press-conference in St. Petersburg. According to him almost all viruses from time to time go through mutation processes which can give them some additional functions."

 http://www.pigprogress.net/Health-Diseases/Outbreaks/2013/7/ASF-could-become-a-human-health-risk-1308047W/

 

 

Background on African Swine Fever Virus as a human pathogen:

"African Swine fever is an endemic disease in sub-Saharan Africa and many other parts of the developing world. It is caused by the African Swine virus that primarily replicates in macrophages and monocytes leading to the impairment of the structure and function of the immune system of the infected organisms. Until now the African Swine epidemic continues to spread despite all efforts to contain it. Thus, there is an objective need for effective, safe and affordable preventive and therapeutic approaches, in particular for effective vaccines, to control and eventually eradicate this disease. Since the characteristic feature of the African Swine virus is to impair the immune system and to cause immune deficiencies in its hosts the development of vaccines and other therapeutic approaches against the African Swine virus has implications for other immune deficiencies or diseases. Several other viruses are also known to cause immunodeficiency-like syndromes in humans, including cytomegalovirus, Epstein Barr Virus and others. Moreover, a series of cases of so-called "idiopathic" immunodeficiencies have been documented that display CD4+T-lymphocytopenia with opportunistic infections, but show no evidence of HIV infection. Since antibodies for the African Swine virus have been detected in humans, the possibility of human infection with the African Swine virus exists and may thus far have escaped any systematic screening. Thus, any preventive and therapeutic approach to African Swine fever can have far-reaching implications to control immune deficiency conditions in humans."http://www.faqs.org/patents/app/20080207875

Detection of Novel Sequences Related to African Swine Fever Virus in Human Serum and Sewage.

Loh J, Zhao G, Presti RM, Holtz LR, Finkbeiner SR, Droit L, Villasana Z, Todd C, Pipas JM, Calgua B, Girones R, Wang D, Virgin HW.

Departments of Pathology & Immunology and Molecular Microbiology, Department of Medicine and Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology, Faculty of Biology, University of Barcelona, Barcelona, Spain.

"The family Asfarviridae contains only a single virus species, African swine fever virus (ASFV). ASFV is a viral agent with significant economic impact due to its devastating effects on populations of domesticated pigs during outbreaks, but has not been reported to infect humans. We report here the discovery of novel viral sequences in human serum and sewage which are clearly related to the Asfarvirus family, but highly divergent from ASFV. Detection of these sequences suggests that greater genetic diversity may exist among Asfarviruses than previously thought, and raises the possibility that human infection by Asfarviruses may occur."

http://www.ncbi.nlm.nih.gov/pubmed/19812170?dopt=Abstract

African Swine Fever Virus (Asfarviridae) sequences found in people with febrile illnesses

Abstract

Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep Sequencing

Dengue virus is an emerging infectious agent that infects an estimated 50–100 million people annually worldwide, yet current diagnostic practices cannot detect an etiologic pathogen in ∼40% of dengue-like illnesses. Metagenomic approaches to pathogen detection, such as viral microarrays and deep sequencing, are promising tools to address emerging and non-diagnosable disease challenges. In this study, we used the Virochip microarray and deep sequencing to characterize the spectrum of viruses present in human sera from 123 Nicaraguan patients presenting with dengue-like symptoms but testing negative for dengue virus. We utilized a barcoding strategy to simultaneously deep sequence multiple serum specimens, generating on average over 1 million reads per sample. We then implemented a stepwise bioinformatic filtering pipeline to remove the majority of human and low-quality sequences to improve the speed and accuracy of subsequent unbiased database searches. By deep sequencing, we were able to detect virus sequence in 37% (45/123) of previously negative cases. These included 13 cases with Human Herpesvirus 6 sequences. Other samples contained sequences with similarity to sequences from viruses in the Herpesviridae, Flaviviridae, Circoviridae, Anelloviridae, Asfarviridae, and Parvoviridae families. In some cases, the putative viral sequences were virtually identical to known viruses, and in others they diverged, suggesting that they may derive from novel viruses. These results demonstrate the utility of unbiased metagenomic approaches in the detection of known and divergent viruses in the study of tropical febrile illness.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274504/

Detection of African swine fever virus-like sequences in ponds in the Mississippi Delta through metagenomic sequencing

" . .. further study is needed to characterize their potential risks to both public health and agricultural development."

http://link.springer.com/article/10.1007%2Fs11262-013-0878-2

ASF virus, adapted to grow in VERO cells, produces a strong cytopathic effect in human macrophages leading to cell destruction.

http://vir.sgmjournals.org/content/34/3/455.short

African Swine Fever Primarily 
Transmitted by Humans
 http://www.aasp.org/news/story.php?id=4824

.
Is this an indication that HHV-8 is really African Swine Fever Virus?

"Primary HHV-8 infection may be associated with fever and a maculopapular rash in immunocompetent children."

http://www.uptodate.com/contents/disease-associations-of-human-herpesvirus-8-infection

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

http://www.ncbi.nlm.nih.gov/pubmed/9607855

Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.

 http://www.ncbi.nlm.nih.gov/pubmed/16501902

 

 Epidemiology of HHV8 in Sardinian emigrants

 http://www.dsnm.univr.it/?ent=progetto&id=565

 Both ASFV and HHV-8 Interfere with apoptosis.

Are ASFV-infected Pigs the viral source of HHV-8 related Kaposi's Sarcoma in Sardinia? Is a ASFV-related Kaposi's Sarcoma epidemic possible in Russia where ASFV is spreading?

 https://hhv6.jottit.com/35._pigs_and_kaposi%27s_sarcoma_in_sardinia

The world's highest incidence of Kaposi's sarcoma occurs in Sardinia (Reference) Is it possible that it is due to the fact that African Swine Fever Virus is endemic on the island? (Reference) One study suggests that the incidence of K.S. in northern Sardinia is highest in a countryside area where people have contact with animals. (Reference) Given the high prevalence of HHV-8,--the so-called K.S. herpes virus--in Sardinia (Reference) is it at all possible that HHV-8 may have been misclassified and actually is a human-adapted form of African Swine Fever Virus? (ASFV has been at least visually mistaken for another herpes virus, CMV, in the past.)

A number of experiments could be conducted to explore this hypothesis. In addition to a direct comparison of ASFV and HHV-8, pigs with African Swine Fever Virus could be tested for sequences of HHV-8. People with Kaposi's sarcoma could be tested for sequences of African Swine Fever, including new Asfaviridae sequences recently discovered. (Reference) 

A comparison of the K.S. lesions in humans and ASFV lesions in pigs might be in order.Given that African Swine Fever is currently spreading in Russia and is now threatening Europe and China, (Reference) it would be useful to know whether people who are exposed to pigs with ASFV are at increased risk for HHV-8, Kaposi's sarcoma and the other pathologies associated with HHV-8. A study in sub-Saharan Africa where ASFV is endemic and HHV-8 is also endemic (Reference) might be useful. And areas of Russia where ASFV is spreading could be monitored closely for any signs of an increase of K.S. or HHV-8 infection and HHV-8 related pathologies.HHV-8 is an emerging health problem. HHV-8-associated K.S. is a significant problem in AIDS patients. It may also be the key to Chronic Fatigue Syndrome. HHV-8 has been found in the cerebrospinal fluid of 50% of Chronic Fatigue Syndrome patients. (Reference) HHV-8 has been linked to type 2 diabetes. (Reference) HHV-8 has been detected in B-cells in Castleman's disease and primary effusion lymphoma. (Reference).

If HHV-8 is a form of ASFV, it is possible that pigs might constitute a useful animal model for the study of possible treatments for K.S. and other pathologies associated with HHV-8. And if there is any relationship between ASFV and HHV-8, people may have to be warned to take special precautions around pigs in areas where there are ASFV outbreaks. And countries where undercooked pork is consumed (like Ukraine where salo is a staple) may need to alert the public to cook all pork products thoroughly during ASFV epidemics.

 

A number of years ago, Neenyah Ostrom reported in the New
York Native on the lesions in CFS patients which seem
to resemble Kaposi's Sarcoma (KS). The current
thinking is that a virus called HHV-8 is the cause of
KS. (Although HHV-6 has recently also been implicated
once again.) If KS is a problem in CFS (and we
suspect it is) then one should be able to find HHV-8 and
HHV-6 in CFS patients. Apparently, in this small
study, one can. Below is a rather explosive abstract:

Prevalence in the cerebrospinal fluid of the following
infectious agents in a cohort of 12 CFS subjects:
human herpes virus-6 and 8; chlamydia species;
mycoplasma species; EBV; CMV; and Coxsackievirus.
Levine, S.
Journal of Chronic Fatigue Syndrome, 2001, 9, 1/2,
41-51.

Abstract:
Over the last decade a wide variety of infectious
agents have been associated with the CFS as potential
etiologies for this disorder. Many of these agents are
neurotrophic and have been linked previously to other
diseases involving the central nervous system (CNS).
Human herpes virus-6 (HHV-6), especially the B
variant, has been found in autopsy specimens of
patients who suffered from MS. Because patients with
CFS manifest a wide range of symptoms involving the
CNS as shown by abnormalities on brain MRIs, SPECT
scans of the brain and results of tilt table testing
we sought to determine the prevalence of HHV-6, HHV-8,
Epstein-Barr Virus (EBV), cytomegalovirus (CMV),
mycoplasma species, chlamydia species, and Coxsackie
virus in the spinal fluid of a group of 12 patients
with CFS (CDC criteria '94).

We found evidence of HHV-6, HHV-8, chlamydia species,
CMV and Coxsackie virus in 6/12 samples. Plasma tests
were negative. It was surprising to obtain such a
relatively high yield of infectious agents in cell
free specimens of spinal fluid that had not been
centrifuged. Future research in spinal fluid analysis,
in addition to testing tissue samples by polymerase
chain reaction (PCR) and other direct viral isolation
techniques will be important in characterizing
subpopulations of CFS patients, especially those with
involvement of the CNS.

The low rate of isolation of HHV-6 may be related to
the lack of gross neurological findings in the
patients at the time of testing.

An overview of KS:http://www.thebody.com/nmai/ks.html

Except for those who have made a lifelong commitment
to denial, finding the so-called "KS virus" (HHV-8)
and the "supporting KS virus" (HHV-6) in CFIDS patients
should help settle the question of the overlapping
nature of the AIDS and CFIDS epidemics.

Isn't it time to take a closer look at those crimson
crescents in the throats of CFIDS patients?

More info on KS here.

Given that HHV-8 is part of the HHV-6 and HHV-7 family, this may be very important:

"The 19R Protein of HHV-6 has significant amino acid sequence homology . . . to a protein encoded by African Swine Fever Virus."

--Glenda L. Lawrence, John Nicholas and Bart G. Barrell
Journal of General virology (1995), 76, 147-152

Should this Dharam Ablashi paper be retracted?

HBLV[HHV-6] is not ASFV.

http://www.researchgate.net/publication/19958785_HBLV_is_not_ASFV

"Other animal species or humans are not infected, but may carry the disease with excretions from the diseased swine."

http://news.postimees.ee/3269151/swine-fever-the-new-normal

 Click here for more information on this issue.

 

African swine fever plagues the third region in Ukraine

http://en.vnews.agency/news/accident/13819-african-swine-fever-plagues-the-third-region-in-ukraine.html

The Horror of African Swine Fever in Eastern Europe

http://www.thepigsite.com/swinenews/40320/the-horror-of-african-swine-fever-in-eastern-europe/

 

 

The International HHV-6 Protest 

and Teach-in At Harvard 

During the HHV-6 Foundation's 9th International 
Conference on HHV-6 & 7

November 9-11, 2015

First protest outside the cocktail reception Sunday, November 8th from 5:00pm – 7:00pm

Overview

Thousands of civil rights activists and public health activists should meet at Harvard during the HHV-6 Foundation's International Conference on HHV-6 & 7 (November 9-11, 2015) to start a new HHV-6 public health and civil rights movement.

They should demand reparations for everyone who has been harmed by the HIV Fraud Ponzi Scheme and the HHV-6 Cover-up.

They should also demand that key players in the HIV Fraud Ponzi Scheme and HHV-6 Cover-up be removed from positions of power and science and medicine: Robert Gallo, Luc Montagnier, Anthony Fauci, Dharam Ablashi, Anthony Komaroff, Henri Agut, Dharam Ablashi, Myron Essex and Phil Pellet. 

Harvard should consider cancelling classes for three days for a HHV-6 Teach-in. HHV-6 will affect the future of every student at Harvard as well as every person on this planet. It deserves this kind of attention.

(More to come.)



Visit the International HHV-6 Protest 
and Teach-in at Harvard Website.

THE CONFERENCE'S ORGANIZING COMMITTEE, SESSION CHAIRS & INVITED SPEAKERS (LIST IN FORMATION)

Philip E. Pellett, PhD, Wayne State University, Co-Chair
Louis Flamand, PhD, MBA, Laval University, Co-Chair
Anthony L. Komaroff, MD, Harvard Medical School, CME Chair & Host
Dharam Ablashi, DVM, HHV-6 Foundation
Henri Agut, MD, PhD, Groupe Hospitalier Pitié-Salpêtrière
Michael Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center
Mary T. Caserta, MD, University of Rochester Medical Center
Vincent Descamps, MD, Bichat Claude Bernard Hospital
Dario DiLuca, PhD, University of Ferrara
Leon G. Epstein, MD, Northwestern University, Feinberg School of Medicine
Niza Frenkel, PhD, Tel Aviv University
Agnes Gautheret-Dejean, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
Ursula Gompels, MSc, PhD, London School of Hygiene and Tropical Medicine
Per Höllsberg, MD, Aarhus University
S. David Hudnall, MD, Yale University School of Medicine
Amy Hudson, PhD, Medical College of Wisconsin
Steven Jacobson, PhD, National Institute of Neurological Disorders and Stroke
Ruth Jarrett, MD, University of Glasgow
Benedikt Kaufer, PhD, Free University of Berlin
Irmeli Lautenschlager, MD, PhD, Helsinki University Hospital and University of Helsinki
Ann Leen, PhD, Baylor College of Medicine
Per Ljungman, MD, PhD, Karolinska University Hospital
Paolo Lusso, MD, PhD , National Institute of Allergy and Infectious Diseases
G. Peter Medveczky, MD, University of South Florida
Yasuko Mori, MD, PhD, Kobe University Graduate School of Medicine
Lieve Naesens, PhD , Rega Institute, Katholieke Universiteit Leuven
Raymund R. Razonable, MD, College of Medicine, Mayo Clinic
Nicola Royle, PhD, University of Leicester
Lawrence J. Stern, PhD, University of Massachusetts Medical School
Koichi Yamanishi, MD, PhD, Osaka University
Tetsushi Yoshikawa, MD, Fujita Health University School of Medicine
Katherine N. Ward, MD, University College London
Danielle Zerr, MD, University of Washington & Seattle Children’s Hospital
Sponsored by: HHV-6 Foundation, Dharam Ablashi, Scientific Director

More on the HHV-6 Conference here.

The HHV-6 Rights of Man

1. The right not to be lied to about the role of HHV-6 in AIDS.

2. The right not to be lied to about the role of HHV-6 in Chronic Fatigue Syndrome.

3. The right not to be lied to about the role of HHV-6 in Autism.

4.The right not to be lied to about the role of HHV-6 in Multiple Sclerosis.

5. The right not to be lied to about the role of HHV-6 in Brain Cancer.

6. The right not to be lied to about the role of HHV-6 in Heart Disease.

7. The right not to be lied to about the role of HHV-6 in Encephalitis.

8. The right not to be lied to about the role of HHV-6 in Cognitive Dysfunction.

9. The right not to be lied to about the role of HHV-6 in Drug Hypersensitivity Syndrome.

10. The right not to be lied to about the role of HHV-6 in Bone Marrow Suppression.

11. The right not to be lied to about the role of HHV-6 in Lymphadenopathy.

 12. The right not to be lied to about the role of HHV-6 in Colitis.

13. The right not to be lied to about the role of HHV-6 in Endocrine Disorders.

14. The right not to be lied to about the role of HHV-6 in Liver Disease.

 15. The right not to be lied to about the role of HHV-6 in Hodgkin's Lymphoma.

 16. The right not to be lied to about the role of HHV-6 in Glioma.

17. The right not to be lied to about the role of HHV-6 in Cervical Cancer.

18. The right not to be lied to about the role of HHV-6 in Hypogammaglobulinemia.

 19. The right not to be lied to about the role of HHV-6 in Optic Neuritis.

20. The right not to be lied to about the role of HHV-6 in Microangiopathy.

21. The right not to be lied to about the role of HHV-6 in Mononucleosis.

22. The right not to be lied to about the role of HHV-6 in Uveitis.

23. The right not to be lied to about the role of HHV-6 in Stevens-Johnson Syndrome.

24. The right not to be lied to about the role of HHV-6 in Rhomboencephalitis.

25. The right not to be lied to about the role of HHV-6 in Limbic Encephalitis.

26. The right not to be lied to about the role of HHV-6 in Encephalomyelitis

27. The right not to be lied to about the role of HHV-6 in Pneumonitis.

28. The right not to be lied to about the role of HHV-6 in GVHD.

29. The right not to be lied to about the role of HHV-6 in Ideopathic Pneumonia.

30. The right not to be lied to about the role of HHV-6 in Pediatric Adrenocortical Tumors

31. The right not to be lied to about the role of HHV-6 in the reactivation of endogenous retroviruses.

32. The right not to be lied to about the impact of HHV-6 on T-Cells.

33. The right not to be lied to about the impact of HHV-6 on B-Cells

34. The right not to be lied to about the impact of HHV-6 on Epithelial Cells.

35. The right not to be lied to about the the impact of HHV-6 on Natural Killer Cells.

36. The right not to be lied to about the the impact of HHV-6 on Dendritic Cells.

37. The right not to be lied to about the the impact of HHV-6 infection of the brain.

 38. The right not to be lied to about the the impact of HHV-6 infection of the liver.

39. The right not to lied to about the ability of HHV-6 to affect cytokine production.

40. The right not to be lied to about the ability of HHV-6 to affect Aortic and Heart Microvascular Endothelial cells.

41. The right not to be lied to about the role of an HHV-6 cover-up in a massive HIV Fraud Ponzi Scheme that in a number of ways resembles the Tuskegee Syphilis Experiment and Nazi medicine.


If HHV-6 is the real cause of AIDS, here are some of the implications:

1. HIV is a massive scientific fraud. Something akin to a Ponzi scheme. Scientists who challenged the HIV theory of AIDS (the ones who have been thuggishly censored and silenced) turn out to be on the money.

2. Chronic Fatigue Syndrome and Autism (and many other so-called HHV-6 related mysterious epidemics) are part of the so-called AIDS epidemic.  Chronic Fatigue Syndrome and Autism both are clearly the results of the ravages of HHV-6.

3. AIDS and Chronic Fatigue Syndrome has been artificially and politically separated into two epidemics. We are living in a period of CFS/AIDS apartheid. So-called AIDS patients have to sit in the back of the HHV-6 epidemic bus while the befuddled HHV-6/CFS patients and HHV-6/Autism victims sit up front. Nobody is well-served.

4. AIDS is not a sexually transmitted disease. That paradigm has set a scapegoating and antigay agenda in place that the public thinks is solidly based on science. It is only based on homophobic and racist nosology, epidemiology and virology. The scientists behind the paradigm are charlatans and crooks.

5. The Centers for Disease Control in Atlanta and the Pasteur Institute in Paris have a great deal in common with the institutions of Nazi medicine. For Blacks, everything these institutions have done in the name of AIDS really constitutes a second Tuskegee Syphilis Experiment.

Elements of a Scientific Ponzi Scheme like the Montagnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up

A scientific Ponzi scheme begins with a central seminal or foundational scientific fraud and is  sometimes built on an infrastructure of smaller scientific frauds. Like the fake dividends issued in a strictly financial Ponzi scheme, a scientific Ponzi scheme issues fake dividends in the form of ongoing fraud-based research often framed as "breakthroughs" and bogus extrapolations which make it look like everything is above board and that what, in reality, is scientific fraud, appears to the rest of the scientific community and the public as good faith progress.

A classic scientific Ponzi scheme like the Montgnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up include elements like these:

1. Nosological fraud.

2. Epidemiological fraud.

3. Virological fraud.

4. Treatment fraud.

5. Public health policy fraud.

6. Concealment of negative scientific data and paradigm-challenging anomalies.

7.  Use of an elite network of "old boys" and pseudo-activist provocateurs to censor critics and whistleblowers.

8. Chronic obscurantism.

9. If necessary, vigilantism and witch-hunts against any intellectuals, scientists, or citizens who constitute any form of resistance to the Ponzi scheme.

10. A subservient scientific press that is used as a conveyor belt for the Ponzi scheme's propaganda.

Everything always looks like it is working perfectly in a Ponzi scheme, until the moment comes when someone look at the books and blows the whistle.  Hopefully, that game-changing moment for the Montagnier-Agut HIV Fraud Ponzi Scheme and HHV-6 Cover-up is coming soon.

It's time to recognize that HHV-6A, HHV-6B, HHV-7 and HHV-8 all belong in a viral category of their own. Leaving them in the herpesvirus family trivializes their impact on public health and turns them into some kind of biomedical joke.

Here are the proposed new names for HHV-6A, HHV-6B, HHV-7 and HHV-8:

The AIDS Spectrum Viruses

HHV-6A should be called AIDS Spectrum Virus 1 (ARV-1)

HHV-6B should be called AIDS Spectrum Virus 2 (ARV-2)

HHV-7 should be called AIDS Spectrum Virus 3 (ARV-3)

HHV-8 should be called AIDS Spectrum Virus 4 (ARV-4)

 The name of Chronic Fatigue Syndrome should be changed to AIDS Spectrum Virus Syndrome 
(AIDS Virus Syndrome or ASVS.)

Black Lives Matter.
Gay Lives Matter.
The Truth about 
HHV-6 Matters. 

Books participants in the International HHV-6 Protest and Teach-in at Harvard (November 9-11, 2015) should read 
in preparation for the big event:

The Virus Within by Nicholas Regush (Print Edition)



What Really Killed Gilda Radner? Frontline Reports on the Chronic Fatigue Syndrome Epidemic by Neenyah Ostrom (Print Edition)

50 Things You Should Know About the Chronic Fatigue Syndrome Epidemic by Neenyah Ostrom (Print Edition)

America's Biggest Cover-Up: 50 More Things Everyone Should Know About the Chronic Fatigue Syndrome Epidemic And Its Link to AIDS by Neenyah Ostrom (Print Edition)

SCIENCE SOLD OUT: DOES HIV REALLY CAUSE AIDS?

The Closing Argument by Charles Ortleb (Available on Kindle and in a Print Edition. Free for Kindle owners with Amazon Prime.)

The HHV-6 Cover-up Must End! 

Buy your HHV-6 t-shirt for the Harvard Protest today at the HHV-6 Store
 

 

HHV-6 Needs a Larry Kramer!

HHV-6University.com

Exercise for Swine Fever emergency photo preview 52182825

http://www.epa.eu/health-photos/diseases-photos/exercise-for-swine-fever-emergency-photos-52182825

The African Swine Fever Virus Rights of Man

1. The right not to be lied to about whether African Swine Fever Virus is infecting human beings.

2. The right not to be lied to about how many different strains of African Swine Fever are capable of infecting humans.

3. The right to know if African Swine Fever is being disguised in pigs by giving it euphemisms of other diseases like PRRS and PEDV.

4. The right not to be lied to about the role of ASFV in AIDS.

5. The right not to be lied to about the role of ASFV in Chronic Fatigue Syndrome.

6. The right not to be lied to about the role of ASFV in Autism.

7.The right not to be lied to about the role of ASFV in Multiple Sclerosis.

8. The right not to be lied to about the role of ASFV in Brain Cancer.

9. The right not to be lied to about the role of ASFV in Heart Disease.

10. The right not to be lied to about the role of ASFV in Encephalitis.

11. The right not to be lied to about the role of ASFV in Cognitive Dysfunction.

12. The right not to be lied to about the role of ASFV in Drug Hypersensitivity Syndrome.

13. The right not to be lied to about the role of ASFV in Bone Marrow Suppression.

14. The right not to be lied to about the role of ASFV in Lymphadenopathy.

 15. The right not to be lied to about the role of ASFV in Colitis.

16. The right not to be lied to about the role of ASFV in Endocrine Disorders.

17. The right not to be lied to about the role of ASFV in Liver Disease.

 18. The right not to be lied to about the role of ASFV in Hodgkin's Lymphoma.

 19. The right not to be lied to about the role of ASFV in Glioma.

20. The right not to be lied to about the role of ASFV in Cervical Cancer.

21. The right not to be lied to about the role of ASFV in Hypogammaglobulinemia.

 22. The right not to be lied to about the role of ASFV in Optic Neuritis.

23. The right not to be lied to about the role of ASFV in Microangiopathy.

24. The right not to be lied to about the role of ASFV in Mononucleosis.

25. The right not to be lied to about the role of ASFV in Uveitis.

26. The right not to be lied to about the role of ASFV in Stevens-Johnson Syndrome.

27. The right not to be lied to about the role of ASFV in Rhomboencephalitis.

28. The right not to be lied to about the role of ASFV in Limbic Encephalitis.

29. The right not to be lied to about the role of ASFV in Encephalomyelitis

30. The right not to be lied to about the role of ASFV in Pneumonitis.

31. The right not to be lied to about the role of ASFV in GVHD.

32. The right not to be lied to about the role of ASFV in Ideopathic Pneumonia.

33. The right not to be lied to about the role of ASFV in Pediatric Adrenocortical Tumors

34. The right not to be lied to about the role of ASFV in the reactivation of endogenous retroviruses.

35. The right not to be lied to about the impact of ASFV on T-Cells.

36. The right not to be lied to about the impact of ASFV on B-Cells

37. The right not to be lied to about the impact of ASFV on Epithelial Cells.

38. The right not to be lied to about the the impact of ASFV on Natural Killer Cells.

39. The right not to be lied to about the the impact of HHV-6 on Dendritic Cells.

40. The right not to be lied to about the the impact of ASFV infection of the brain.

 41. The right not to be lied to about the the impact of ASFV infection of the liver.

42. The right not to lied to about the ability of ASFV to affect cytokine production.

43. The right not to be lied to about the ability of ASFV to affect Aortic and Heart Microvascular Endothelial cells.

44. The right not be lied to about the relationship of ASFV to HHV-6, HHV-7 and HHV-8. 





Background: 

John Beldekas on HHV-6 and 
African Swine Fever Virus 

In August, 1986, John Beldekas was invited to go to the NCI and present his findings on the link between ASFV [African Swine Fever virus] and AIDS, which he did. Beldekas gave samples of all his lab work to Gallo. Later, the government asked Beldekas to turn over all his reagents and lab work to the government, which he did. Beldekas had found ASFV presence in nine of 21 AIDS patients using two standard procedures. At the meeting, Gallo was reported saying: “we know it is not ASFV.” How could Gallo know this as he hadn’t done any of his own tests to look for ASFV?
Two months later, Gallo published an article in Science (Oct 31, 1986) that he discovered a new possible co-factor in AIDS, a virus he called Human B Cell Lymphotropic Virus which he named HBLV. Like ASFV, HBLV infected B cells and also lived in macrophages. Did Gallo steal Beldekas’s ASF virus he found in AIDS patients and rename it HBLV? Later on, when Gallo found that HBLV could also infect other immune cells, he changed the name of HBLV to HHV-6. Eventually, Gallo identified his HBLV as the variant A strain of HHV-6 and called it a human herpesvirus.
--Mark Konlee

http://www.keephopealive.org/report10.html

Russian Scientist: ASF could become a human health risk

"The African swine fever (ASF) virus, may in the future become dangerous for humans, according to the head of the Russian Epidemiology Service, Chief State Sanitary Doctor Gennady Onishchenko, at the press-conference in St. Petersburg. According to him almost all viruses from time to time go through mutation processes which can give them some additional functions."

 http://www.pigprogress.net/Health-Diseases/Outbreaks/2013/7/ASF-could-become-a-human-health-risk-1308047W/

 

 

Background on African Swine Fever Virus as a human pathogen:

"African Swine fever is an endemic disease in sub-Saharan Africa and many other parts of the developing world. It is caused by the African Swine virus that primarily replicates in macrophages and monocytes leading to the impairment of the structure and function of the immune system of the infected organisms. Until now the African Swine epidemic continues to spread despite all efforts to contain it. Thus, there is an objective need for effective, safe and affordable preventive and therapeutic approaches, in particular for effective vaccines, to control and eventually eradicate this disease. Since the characteristic feature of the African Swine virus is to impair the immune system and to cause immune deficiencies in its hosts the development of vaccines and other therapeutic approaches against the African Swine virus has implications for other immune deficiencies or diseases. Several other viruses are also known to cause immunodeficiency-like syndromes in humans, including cytomegalovirus, Epstein Barr Virus and others. Moreover, a series of cases of so-called "idiopathic" immunodeficiencies have been documented that display CD4+T-lymphocytopenia with opportunistic infections, but show no evidence of HIV infection. Since antibodies for the African Swine virus have been detected in humans, the possibility of human infection with the African Swine virus exists and may thus far have escaped any systematic screening. Thus, any preventive and therapeutic approach to African Swine fever can have far-reaching implications to control immune deficiency conditions in humans."http://www.faqs.org/patents/app/20080207875

Detection of Novel Sequences Related to African Swine Fever Virus in Human Serum and Sewage.

Loh J, Zhao G, Presti RM, Holtz LR, Finkbeiner SR, Droit L, Villasana Z, Todd C, Pipas JM, Calgua B, Girones R, Wang D, Virgin HW.

Departments of Pathology & Immunology and Molecular Microbiology, Department of Medicine and Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Microbiology, Faculty of Biology, University of Barcelona, Barcelona, Spain.

"The family Asfarviridae contains only a single virus species, African swine fever virus (ASFV). ASFV is a viral agent with significant economic impact due to its devastating effects on populations of domesticated pigs during outbreaks, but has not been reported to infect humans. We report here the discovery of novel viral sequences in human serum and sewage which are clearly related to the Asfarvirus family, but highly divergent from ASFV. Detection of these sequences suggests that greater genetic diversity may exist among Asfarviruses than previously thought, and raises the possibility that human infection by Asfarviruses may occur."

http://www.ncbi.nlm.nih.gov/pubmed/19812170?dopt=Abstract

African Swine Fever Virus (Asfarviridae) sequences found in people with febrile illnesses

Abstract

Virus Identification in Unknown Tropical Febrile Illness Cases Using Deep Sequencing

Dengue virus is an emerging infectious agent that infects an estimated 50–100 million people annually worldwide, yet current diagnostic practices cannot detect an etiologic pathogen in ∼40% of dengue-like illnesses. Metagenomic approaches to pathogen detection, such as viral microarrays and deep sequencing, are promising tools to address emerging and non-diagnosable disease challenges. In this study, we used the Virochip microarray and deep sequencing to characterize the spectrum of viruses present in human sera from 123 Nicaraguan patients presenting with dengue-like symptoms but testing negative for dengue virus. We utilized a barcoding strategy to simultaneously deep sequence multiple serum specimens, generating on average over 1 million reads per sample. We then implemented a stepwise bioinformatic filtering pipeline to remove the majority of human and low-quality sequences to improve the speed and accuracy of subsequent unbiased database searches. By deep sequencing, we were able to detect virus sequence in 37% (45/123) of previously negative cases. These included 13 cases with Human Herpesvirus 6 sequences. Other samples contained sequences with similarity to sequences from viruses in the Herpesviridae, Flaviviridae, Circoviridae, Anelloviridae, Asfarviridae, and Parvoviridae families. In some cases, the putative viral sequences were virtually identical to known viruses, and in others they diverged, suggesting that they may derive from novel viruses. These results demonstrate the utility of unbiased metagenomic approaches in the detection of known and divergent viruses in the study of tropical febrile illness.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274504/

Detection of African swine fever virus-like sequences in ponds in the Mississippi Delta through metagenomic sequencing

" . .. further study is needed to characterize their potential risks to both public health and agricultural development."

http://link.springer.com/article/10.1007%2Fs11262-013-0878-2

ASF virus, adapted to grow in VERO cells, produces a strong cytopathic effect in human macrophages leading to cell destruction.

http://vir.sgmjournals.org/content/34/3/455.short

African Swine Fever Primarily 
Transmitted by Humans
 http://www.aasp.org/news/story.php?id=4824

.
Is this an indication that HHV-8 is really African Swine Fever Virus?

"Primary HHV-8 infection may be associated with fever and a maculopapular rash in immunocompetent children."

http://www.uptodate.com/contents/disease-associations-of-human-herpesvirus-8-infection

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

http://www.ncbi.nlm.nih.gov/pubmed/9607855

Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.

 http://www.ncbi.nlm.nih.gov/pubmed/16501902

 

 Epidemiology of HHV8 in Sardinian emigrants

 http://www.dsnm.univr.it/?ent=progetto&id=565

 Both ASFV and HHV-8 Interfere with apoptosis.

Are ASFV-infected Pigs the viral source of HHV-8 related Kaposi's Sarcoma in Sardinia? Is a ASFV-related Kaposi's Sarcoma epidemic possible in Russia where ASFV is spreading?

 https://hhv6.jottit.com/35._pigs_and_kaposi%27s_sarcoma_in_sardinia

The world's highest incidence of Kaposi's sarcoma occurs in Sardinia (Reference) Is it possible that it is due to the fact that African Swine Fever Virus is endemic on the island? (Reference) One study suggests that the incidence of K.S. in northern Sardinia is highest in a countryside area where people have contact with animals. (Reference) Given the high prevalence of HHV-8,--the so-called K.S. herpes virus--in Sardinia (Reference) is it at all possible that HHV-8 may have been misclassified and actually is a human-adapted form of African Swine Fever Virus? (ASFV has been at least visually mistaken for another herpes virus, CMV, in the past.)

A number of experiments could be conducted to explore this hypothesis. In addition to a direct comparison of ASFV and HHV-8, pigs with African Swine Fever Virus could be tested for sequences of HHV-8. People with Kaposi's sarcoma could be tested for sequences of African Swine Fever, including new Asfaviridae sequences recently discovered. (Reference) 

A comparison of the K.S. lesions in humans and ASFV lesions in pigs might be in order.Given that African Swine Fever is currently spreading in Russia and is now threatening Europe and China, (Reference) it would be useful to know whether people who are exposed to pigs with ASFV are at increased risk for HHV-8, Kaposi's sarcoma and the other pathologies associated with HHV-8. A study in sub-Saharan Africa where ASFV is endemic and HHV-8 is also endemic (Reference) might be useful. And areas of Russia where ASFV is spreading could be monitored closely for any signs of an increase of K.S. or HHV-8 infection and HHV-8 related pathologies.HHV-8 is an emerging health problem. HHV-8-associated K.S. is a significant problem in AIDS patients. It may also be the key to Chronic Fatigue Syndrome. HHV-8 has been found in the cerebrospinal fluid of 50% of Chronic Fatigue Syndrome patients. (Reference) HHV-8 has been linked to type 2 diabetes. (Reference) HHV-8 has been detected in B-cells in Castleman's disease and primary effusion lymphoma. (Reference).

If HHV-8 is a form of ASFV, it is possible that pigs might constitute a useful animal model for the study of possible treatments for K.S. and other pathologies associated with HHV-8. And if there is any relationship between ASFV and HHV-8, people may have to be warned to take special precautions around pigs in areas where there are ASFV outbreaks. And countries where undercooked pork is consumed (like Ukraine where salo is a staple) may need to alert the public to cook all pork products thoroughly during ASFV epidemics.

 

A number of years ago, Neenyah Ostrom reported in the New
York Native on the lesions in CFS patients which seem
to resemble Kaposi's Sarcoma (KS). The current
thinking is that a virus called HHV-8 is the cause of
KS. (Although HHV-6 has recently also been implicated
once again.) If KS is a problem in CFS (and we
suspect it is) then one should be able to find HHV-8 and
HHV-6 in CFS patients. Apparently, in this small
study, one can. Below is a rather explosive abstract:

Prevalence in the cerebrospinal fluid of the following
infectious agents in a cohort of 12 CFS subjects:
human herpes virus-6 and 8; chlamydia species;
mycoplasma species; EBV; CMV; and Coxsackievirus.
Levine, S.
Journal of Chronic Fatigue Syndrome, 2001, 9, 1/2,
41-51.

Abstract:
Over the last decade a wide variety of infectious
agents have been associated with the CFS as potential
etiologies for this disorder. Many of these agents are
neurotrophic and have been linked previously to other
diseases involving the central nervous system (CNS).
Human herpes virus-6 (HHV-6), especially the B
variant, has been found in autopsy specimens of
patients who suffered from MS. Because patients with
CFS manifest a wide range of symptoms involving the
CNS as shown by abnormalities on brain MRIs, SPECT
scans of the brain and results of tilt table testing
we sought to determine the prevalence of HHV-6, HHV-8,
Epstein-Barr Virus (EBV), cytomegalovirus (CMV),
mycoplasma species, chlamydia species, and Coxsackie
virus in the spinal fluid of a group of 12 patients
with CFS (CDC criteria '94).

We found evidence of HHV-6, HHV-8, chlamydia species,
CMV and Coxsackie virus in 6/12 samples. Plasma tests
were negative. It was surprising to obtain such a
relatively high yield of infectious agents in cell
free specimens of spinal fluid that had not been
centrifuged. Future research in spinal fluid analysis,
in addition to testing tissue samples by polymerase
chain reaction (PCR) and other direct viral isolation
techniques will be important in characterizing
subpopulations of CFS patients, especially those with
involvement of the CNS.

The low rate of isolation of HHV-6 may be related to
the lack of gross neurological findings in the
patients at the time of testing.

An overview of KS:http://www.thebody.com/nmai/ks.html

Except for those who have made a lifelong commitment
to denial, finding the so-called "KS virus" (HHV-8)
and the "supporting KS virus" (HHV-6) in CFIDS patients
should help settle the question of the overlapping
nature of the AIDS and CFIDS epidemics.

Isn't it time to take a closer look at those crimson
crescents in the throats of CFIDS patients?

More info on KS here.

Given that HHV-8 is part of the HHV-6 and HHV-7 family, this may be very important:

"The 19R Protein of HHV-6 has significant amino acid sequence homology . . . to a protein encoded by African Swine Fever Virus."

--Glenda L. Lawrence, John Nicholas and Bart G. Barrell
Journal of General virology (1995), 76, 147-152

Should this Dharam Ablashi paper be retracted?

HBLV[HHV-6] is not ASFV.

http://www.researchgate.net/publication/19958785_HBLV_is_not_ASFV

"Other animal species or humans are not infected, but may carry the disease with excretions from the diseased swine."

http://news.postimees.ee/3269151/swine-fever-the-new-normal

 Click here for more information on this issue.

 

 

 

http://www.globalmeatnews.com/Industry-Markets/African-Swine-Fever-puts-Russian-region-at-risk